Details for 2010182610

Up to date per 03.04.2026

Actions

Title / Product Name

Formulierung humaner Antikörper zur Behandlung von TNF-alpha-assoziierten Erkrankungen

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2010182610

EP Publication Number

2359856

E-Number

891615

Language

PCT Number

Publication Date

24.08.2011 A

10.05.2017 B1

Registration Date

10.05.2017

AT Publication Date

15.05.2017

Application Date

15.08.2003

Registration Number

Priorities

16.08.2002

222140

IPC

A61K 39/395 20060101AFI20110715BHEP

Maximum Duration of Protection

15.08.2023

Owner

AbbVie Biotechnology Ltd.Clarendon House 2, Church Street HM 11 HamiltonBM

Representative

Dr. Müllner Dipl.-Ing. Katschinka OG PatentanwaltskanzleiWeihburggasse 91010 WienAT

Inventor

Krause, Hans-JuergenSt. Killian-Strasse 14 67269 GruenstadtDE

Baust, LisaGoethetr. 15a 67063 LudwigshafenDE

Dickes, MichaelSchafergasse 58 67127 Rodersheim-GronauDE